This chapter examines the prevalence, reasons, and forms of strategic alliances in biopharmaceutical firms. It also addresses the potential threats that occur in strategic alliances.
Strategic alliances are an integral part of the biopharmaceutical industry. Strategic alliances are agreements among entities in which each party commits complementary resources or capabilities to achieve a common set of objectives. Research has found that young biopharmaceutical firms receive more funds from other biopharmaceutical firms via strategic alliances than all other sources.1, 2 Throughout the second ...